Effects of thiazolidinediones on cardiovascular risk factors.
作者信息
Gouda Biswanath P, Asnani Sunil, Fonseca Vivian A
机构信息
Department of Medicine, Section of Endocrinology, Tulane University Health Sciences Center, New Orleans, LA, USA.
出版信息
Compr Ther. 2002 Winter;28(4):200-6. doi: 10.1007/s12019-002-0018-8.
PMID:12506489
Abstract
The thiazolidinediones are the insulin sensitizers used in the management of Type 2 diabetes mellitus. These drugs can potentially decrease the risk of cardiovascular disease by correcting the different components of the insulin resistance syndrome.
摘要
Zotero 插件